Arrow-right Camera
The Spokesman-Review Newspaper

The Spokesman-Review Newspaper The Spokesman-Review

Spokane, Washington  Est. May 19, 1883
Partly Cloudy Day 67° Partly Cloudy
News >  Business

FDA approves diabetes drug that also helps with weight loss

UPDATED: Tue., Dec. 5, 2017

By By Linda A. Johnson Associated Press

TRENTON, N.J. – U.S. regulators have approved a new diabetes drug that reduces blood sugar levels and also helps people lose weight.

The Food and Drug Administration on Tuesday approved the once-a-week shot for people with Type 2 diabetes.

Danish drugmaker Novo Nordisk says the drug will cost about the same as similar drugs at $676 for a four- to six-week supply without insurance.

The drug, called Ozempic, comes in injector pens. It stimulates insulin production and reduces appetite.

On average, the medicine reduced long-term blood sugar levels at least 2 1/2 times as much as a popular daily diabetes pill in one big study. It also helped study participants lose two to three times as much weight as those in the comparison group given Merck & Co.’s Januvia.

The Spokesman-Review Newspaper

Local journalism is essential.

Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are not tax deductible, but are predominately used to help meet the local financial requirements needed to receive national matching-grant funds.

Active Person

Subscribe now to get breaking news alerts in your email inbox

Get breaking news delivered to your inbox as it happens.